| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445398 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
Our results provide evidence that early initiation of chemotherapy might result in slightly improved survival in patients with complete cytoreduction while patients with residual disease after surgery did not benefit from earlier chemotherapy. A prospective study randomising patients to different time intervals could clarify the definitive relevance of the time between surgery and chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Mahner, C. Eulenburg, A. Staehle, K. Wegscheider, A. Reuss, E. Pujade-Lauraine, P. Harter, I. Ray-Coquard, J. Pfisterer, A. du Bois,